Patient Demo

See how uploading patient data improves drug recommendations

Enhanced Matching with Data Sharing

See how biopharma companies sharing their unpublished data creates better matches

Patient Profile

Conditions

Amyotrophic Lateral Sclerosis (ALS)
Severity: moderate • ICD-10: G12.21
triglycerides:85
creatine kinase:450
neurofilament light:120

Current Medications

  • Riluzole
  • Edaravone

Key Biomarkers

triglycerides:85
glucose:92
weight:165

Alternative candidate therapies(1 option found)

BIOIO-1001

89% MatchTop Alternative
BIOIOPhase 1

Your low triglyceride level (85 mg/dL) is problematic in ALS. BIOIO-1001 paradoxically raises triglycerides in ALS models, which improves energy metabolism in this nutrient-deficient disease state. Animal studies show 28% survival extension.

Why Share Your Data?

1.

More Accurate Matches: Your data helps the algorithm learn which therapies work best for people like you, leading to better recommendations.

2.

Earn Rewards: Get preferential pricing on candidate therapies and priority access to new treatments.

3.

Access Hidden Opportunities: When you enable enhanced matching, you'll see private indications from biopharma companies that might be life-saving.